Main > GASTROENTEROLOGY > Short Bowel Syndrome > Treatment > Teduglutide Recombinant GLP-2 > Co.: USA. N. (Phase III/Patents)
Co.: USA. N. (Phase III/Patents)'s subsections
Company
Partner (Non-USA)
Patent>Assignees; Claims; No., Etc.
Patent>Total USA No.: 3
Patent>UpDate: 10.09.07
Top-Line Results
TradeMark
UpDate: 05.08.08. (PR)
Co.: USA. N. (Phase III/Patents)'s products
This section has no products